Related Experiment Videos

Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1

D G Alleva1, S B Kaser, D I Beller

  • 1Evans Memorial Department of Clinical Research, Boston University Medical Center, MA 02118-2393, USA. dgalleva@bu.edu

Insights

Macrophages from lupus-prone mice exhibit early defects in pro-inflammatory cytokine production, specifically TNF-alpha, impacting IL-1 and IL-6. These findings offer insights into innate immune system dysfunction in systemic autoimmunity.

Area of Science:

  • Immunology
  • Autoimmunity
  • Innate Immune System

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
  • Macrophages (Mphi) play a critical role in immune regulation.
  • Early functional defects in Mphi may contribute to lupus pathogenesis.

Purpose of the Study:

  • To investigate common immunoregulatory cytokine production defects in macrophages from young, lupus-prone mouse models.
  • To identify early molecular and cellular dysfunctions preceding overt disease in lupus.

Main Methods:

  • Comparison of endotoxin-activated Mphi from lupus-prone (MRL+/+ and NZB/W F1) and normal (BALB/c, A/J, C57BL/6) mice.
  • Quantification of interleukin-1 (IL-1), IL-6, tumor necrosis factor-alpha (TNF-alpha), and IL-10 production.
  • Assessment of cytokine dysregulation using exogenous cytokine treatments and neutralizing antibodies.

Main Results:

  • Mphi from lupus-prone mice showed reduced IL-1, IL-6, and TNF-alpha production before disease onset.
  • Defective TNF-alpha production was the earliest defect and appeared responsible for aberrant IL-1 and IL-6 levels.
  • Interferon-gamma (IFN-gamma) normalized TNF-alpha production, indicating stimulus-specific defects.
  • Normal Mphi exhibited an inverse TNF-alpha/IL-10 relationship, absent in lupus-prone Mphi.

Conclusions:

  • Shared cytokine production defects in macrophages from distinct lupus models suggest intrinsic immune system dysfunction.
  • Early dysregulation of pro-inflammatory cytokines by macrophages may be a key factor in lupus development.
  • Targeting macrophage function or innate immune pathways could offer novel therapeutic strategies for SLE.

Related Concept Videos